Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma

Targeting androgen receptor (AR) has been shown to be promising in treating glioblastoma (GBM) in cell culture and flank implant models but the mechanisms remain unclear. AR antagonists including enzalutamide are available for treating prostate cancer patients in clinic and can pass the blood–brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nan, Wang, Fei, Ahmed, Shaheen, Liu, Kan, Zhang, Chi, Cathcart, Sahara J., DiMaio, Dominick J., Punsoni, Michael, Guan, Bingjie, Zhou, Ping, Wang, Shuo, Batra, Surinder K., Bronich, Tatiana, Hei, Tom K., Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175980/
https://www.ncbi.nlm.nih.gov/pubmed/34094902
http://dx.doi.org/10.3389/fonc.2021.616625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175980/
https://www.ncbi.nlm.nih.gov/pubmed/34094902
http://dx.doi.org/10.3389/fonc.2021.616625

Ejemplares similares